Target
3-phosphoinositide-dependent protein kinase 1 [51-359]
Ligand
BDBM282473
Substrate
n/a
Meas. Tech.
PDK1 kinase assay
IC50
<100±n/a nM
Citation
 Arndt, JChan, TGuckian, KKumaravel, GLee, WLin, EYScott, DSun, LThomas, Jvan Vloten, KWang, DZhang, LErlanson, D Heterocyclic compounds useful as PDK1 inhibitors US Patent  US10030016 Publication Date 7/24/2018 
Target
Name:
3-phosphoinositide-dependent protein kinase 1 [51-359]
Synonyms:
3-Phosphoinositide-Dependent Protein Kinase 1 (PDK1) | 3-phosphoinositide-dependent protein kinase 1 | 3-phosphoinositide-dependent protein kinase 1 (aa 51-359) | PDK1 | PDK1 (aa 51-359) | PDPK1 | PDPK1_HUMAN | hPDK1
Type:
Enzyme Catalytic Domain
Mol. Mass.:
35302.26
Organism:
Homo sapiens (Human)
Description:
O15530[51-359]
Residue:
309
Sequence:
MDGTAAEPRPGAGSLQHAQPPPQPRKKRPEDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHGKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANSFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAGNEYLIFQKIIKLEYDFPEKFFPKARDLVEKLLVLDATKRLGCEEMEGYGPLKAHPFFESVTWENLHQQTPPKLT
  
Inhibitor
Name:
BDBM282473
Synonyms:
3-((S)-1-(4-(3-amino-1H- pyrazolo[3,4-b]pyridin- 5-yl)phenyl)-2-hydroxy- ethylamino)-6-cyano-N- ((S)-1-(3,4-difluorophenyl) ethyl)pyrazine-2-carboxamide | US10030016, Example 353
Type:
Small organic molecule
Emp. Form.:
C28H23F2N9O2
Mol. Mass.:
555.5381
SMILES:
C[C@H](NC(=O)c1nc(cnc1N[C@H](CO)c1ccc(cc1)-c1cnc2[nH]nc(N)c2c1)C#N)c1ccc(F)c(F)c1 |r|
Structure:
Search PDB for entries with ligand similarity: